Skip to main content

Table 3 Postoperative adverse events before and after propensity score matching analysis in UICC T3 HCC patients

From: Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study

Variables

Before PSM

After PSM

TACE (n = 899) HR (n = 280) P value

TACE (n = 244) HR (n = 244) P value

Pain (0–2/3–4)

899/1

278/2

0.142*

243/1

243/1

1.0

Edema (0–2/3–4)

899/2

277/3

0.031*

243/1

242/2

1.0*

Fever (0–2/3–4)

883/16

267/13

0.007

241/3

240/4

1.0*

Vomiting (0–2/3–4)

888/11

278/2

0.70#

238/6

242/2

0.285*

Ascites (0–2/3–4)

896/3

275/5

0.03#

242/2

240/4

0.686*

Pleural effusion (0–2/3–4)

897/2

264/16

< 0.01#

243/1

231/13

0.01

UGIH/POH (0–2/3–4)

897/2

278/2

0.241*

243/1

242/2

1.0*

Renal failure (0/1–2)

896/3

279/1

1.0*

243/1

242/2

1.0*

Liver dysfunction (0–2/3–4)

898/1

278/2

0.142*

243/1

243/1

1.0

Bile leakage (n/y)

898/1

279/1

0.422*

244/1

243/1

1.0*

TRD

897/2

277/3

0.090*

243/1

243/1

1.0*

  1. Abbreviations: UICC the Union for International Cancer Control, UGIH upper gastrointestinal hemorrhage, POH postoperative hemorrhage, TRD treatment-related death, PSM propensity score matching
  2. * Fisher’ exact test. # χ2 test with a continuity correction
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us